Actions and therapeutic pathways of ghrelin for gastrointestinal disorders.
about
Ghrelin - a pleiotropic hormone secreted from endocrine x/a-like cells of the stomachUse of ghrelin as a treatment for inflammatory bowel disease: mechanistic considerationsStomach dysfunction in diabetes mellitus: emerging technology and pharmacologyCyclic vomiting syndrome and functional vomiting in adults: association with cannabinoid use in males.Integrating GHS into the Ghrelin System.Randomized controlled phase Ib study of ghrelin agonist, RM-131, in type 2 diabetic women with delayed gastric emptying: pharmacokinetics and pharmacodynamics.Ghrelin and motilin receptor agonists: time to introduce bias into drug design.Abdominal surgery inhibits circulating acyl ghrelin and ghrelin-O-acyltransferase levels in rats: role of the somatostatin receptor subtype 2.The hungry stomach: physiology, disease, and drug development opportunities.Stress-related alterations of acyl and desacyl ghrelin circulating levels: mechanisms and functional implications.Emerging treatments in Neurogastroenterology: relamorelin: a novel gastrocolokinetic synthetic ghrelin agonist.Early investigational therapeutics for gastrointestinal motility disorders: from animal studies to Phase II trials.Effect of rikkunshi-to treatment on chemotherapy-induced appetite loss in patients with lung cancer: A prospective study.The ghrelin agonist RM-131 accelerates gastric emptying of solids and reduces symptoms in patients with type 1 diabetes mellitusMotilin: towards a new understanding of the gastrointestinal neuropharmacology and therapeutic use of motilin receptor agonists.Adiposopathy and bariatric surgery: is 'sick fat' a surgical disease?Altered GI motility in critically Ill patients: current understanding of pathophysiology, clinical impact, and diagnostic approach.The prokinetic face of ghrelin.From longitudinal gastric resection to sleeve gastrectomy--revival of a previously established surgical procedure.Peptide and protein drugs: the study of their metabolism and catabolism by mass spectrometry.A ghrelin agonist fails to show benefit in patients with diabetic gastroparesis: let's not throw the baby out with the bath water.Gastric residual volume in critically ill patients: a dead marker or still alive?Therapeutic applications of ghrelin agonists in the treatment of gastroparesis.Ghrelin receptors as targets for novel motility drugs.Current advances in treatment of gastroparesis.Ghrelin and motilin receptors as drug targets for gastrointestinal disorders.Motion Sickness: Current Knowledge and Recent Advance.Emerging strategies for the treatment of gastroparesis.Safety of treatment for gastroparesis.Neuroimmune Modulation of Gut Function.Effect of DA-9701, a Novel Prokinetic Agent, on Post-operative Ileus in Rats.Cold ambient temperature reverses abdominal surgery-induced delayed gastric emptying and decreased plasma ghrelin levels in ratsGhrelin prevents levodopa-induced inhibition of gastric emptying and increases circulating levodopa in fasted rats.Effects of ghrelin receptor agonist, relamorelin, on gastric motor functions and satiation in healthy volunteers.The Impact of Ghrelin in Metabolic Diseases: An Immune PerspectiveGhrelin and Motilin Control Systems in GI Physiology and Therapeutics.Preventive effect of rikkunshito on gastric motor function inhibited by L-dopa in rats.Ghrelin and Obesity: Identifying Gaps and Dispelling Myths. A Reappraisal.Short-Term Effects of Relamorelin on Descending Colon Motility in Chronic Constipation: A Randomized, Controlled Trial.Nitric oxide regulation of migrating motor complex: randomized trial of N(G)-monomethyl-L-arginine effects in relation to muscarinic and serotonergic receptor blockade.
P2860
Q21129364-F351DD7A-6D9F-4E05-AF93-A0523638F2D3Q30431058-50CBAD6B-B5E1-4D83-9CFB-F8C1B255DBE3Q33674557-5E86D58C-CEDA-481A-A6AA-E7BD49F0063DQ34028713-37206BCD-B5A6-4EFA-847F-ED05BD82ED3EQ34078389-751EA22F-DD79-44B6-9FBB-A0C43284D9D9Q34298494-7C1DF449-E640-492B-9CC2-BAFEF8F5F1CDQ34398651-A221C3C1-7FCB-4358-A6E4-2CD67F6EFE48Q35159637-46DB5D50-A212-49E7-9968-8911F41816A7Q35215647-FBE1C95D-2B17-4C86-BA1A-479927478D7AQ35563403-C8E448FB-0F41-4E0C-A888-082B24F082C8Q35584740-4A9A20D7-8801-4337-9B14-65D03E66EEFDQ36082843-84CB63B3-EC19-4082-9694-53EDD25D9096Q36502184-A786121B-C3E4-433B-8D8A-5727AC53DA02Q37248624-89C0A3B4-F7DD-46B6-835E-547C24028EDAQ37337819-BBC8A057-1DB2-4BF8-A5A8-D6C667ECFCB7Q37427308-F3BE6ECE-9F3E-4B3F-9FB6-A70A97454581Q37686923-7CE8F85F-1944-4400-9890-0893831AF949Q37780960-03355D92-35D0-4143-8B8F-4836DF672945Q37781297-68C9B2CB-EF84-49A0-BB00-6B8BBD18A6F7Q37893563-AD0B3607-E38C-4D52-B6AD-072CD466C729Q38133838-076F982D-8B86-440A-A9A9-80156913CA7BQ38294312-CF389724-F001-4F73-933E-873E352A4627Q38363587-2E6A5A63-D655-4DBB-A923-10FA12DC5A68Q38436184-BD3584DE-A4CA-447E-B7E4-5AF62E6AD923Q38550545-D5309387-BAED-4C56-A249-E0579990AE68Q38590705-EBC8F4F1-9578-4D9F-A682-4A3AA83FFFDAQ38603260-1AE5971F-7343-4F59-B5EC-4F0A83F21F5CQ38721476-F48358C7-FBC1-4276-B516-DE114CCC49F2Q38794290-B749197E-E1E0-4A7B-928F-DBB068AAE241Q40431964-10391940-9A5B-4A25-8524-51E0D04FCB98Q40849145-76E6827F-7A03-4AA0-A4AB-193A421F493CQ41861653-891B3627-B89D-4439-88BF-2812A2A7BC81Q42150469-73073452-A7DE-4466-89A6-F7E3F3143339Q42721572-E3187BB4-6036-42FD-8634-4D4409C55361Q42730636-09675B91-A41B-49A7-9B48-2DD398ED1987Q43358150-C15DC71C-8535-4930-A008-76E8066F8BCBQ43685308-A6A51BDF-81F1-4D67-9B95-6A2C88A51AD2Q49463743-3F3F1A58-C242-4330-BC6C-460C89AD1440Q51295486-67D02F18-E7F6-4B9C-880F-CE37FAD3046EQ51299957-33D93EF3-D6D6-4C34-9C65-F7FDA5D1EC68
P2860
Actions and therapeutic pathways of ghrelin for gastrointestinal disorders.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Actions and therapeutic pathways of ghrelin for gastrointestinal disorders.
@en
Actions and therapeutic pathways of ghrelin for gastrointestinal disorders.
@nl
type
label
Actions and therapeutic pathways of ghrelin for gastrointestinal disorders.
@en
Actions and therapeutic pathways of ghrelin for gastrointestinal disorders.
@nl
prefLabel
Actions and therapeutic pathways of ghrelin for gastrointestinal disorders.
@en
Actions and therapeutic pathways of ghrelin for gastrointestinal disorders.
@nl
P2860
P356
P1476
Actions and therapeutic pathways of ghrelin for gastrointestinal disorders.
@en
P2093
Athanasios Papathanasopoulos
Suwebatu T Odunsi
P2860
P2888
P304
P356
10.1038/NRGASTRO.2009.72
P407
P577
2009-06-01T00:00:00Z